36 min listen
Biotech Cash Management with Allan Shaw
ratings:
Length:
48 minutes
Released:
Aug 7, 2023
Format:
Podcast episode
Description
It’s been said that clinical trials are where emerging biotechs go to die. If the science doesn't kill quickly, poor cash management will slowly. And, even when good data opens the cash floodgates, post-round cash management savvy isn't necessarily intuitive to academic and scientific founders. Cash runway preservation is, however, ingrained in the cerebral cortex of one of our favorite mavens of biotech finance markets and management, Mr. Allan Shaw. He joins us on this week’s episode of the Business of Biotech for a conversation on post-financing fundamentals for new and emerging biopharmas.Subscribe to the NEW #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!
Released:
Aug 7, 2023
Format:
Podcast episode
Titles in the series (100)
004: Finding Funding In Volatile Times With Dr. Ben Zeskind by Business Of Biotech